Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT02743494




Registration number
NCT02743494
Ethics application status
Date submitted
15/04/2016
Date registered
19/04/2016
Date last updated
18/09/2023

Titles & IDs
Public title
An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer
Scientific title
A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects With Resected Esophageal, or Gastroesophageal Junction Cancer
Secondary ID [1] 0 0
2015-005556-10
Secondary ID [2] 0 0
CA209-577
Universal Trial Number (UTN)
Trial acronym
CheckMate 577
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Advanced Cancer 0 0
Condition category
Condition code

Intervention/exposure
Study type
Interventional(has expanded access)
Description of intervention(s) / exposure
Treatment: Drugs - Nivolumab
Other interventions - Placebo

Experimental: Nivolumab -

Placebo comparator: Placebo -


Treatment: Drugs: Nivolumab
Specified dose on specified days

Other interventions: Placebo
Specified dose on specified days
Intervention code [1] 0 0
Treatment: Drugs
Intervention code [2] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Disease-free Survival (DFS)
Timepoint [1] 0 0
From randomization to the date of recurrence or death (up to approximately 46 months)
Secondary outcome [1] 0 0
Overall Survival (OS)
Timepoint [1] 0 0
From randomization to the date of death (up to approximately 46 months)
Secondary outcome [2] 0 0
Overall Survival Rate
Timepoint [2] 0 0
From randomization to 1, 2 and 3 years later

Eligibility
Key inclusion criteria
* Diagnosed with Stage II/III carcinoma of the esophagus or gastroesophageal junction
* Completed pre-operative chemo radiotherapy followed by surgery
* Diagnosed with residual pathologic disease after being surgically rendered free of disease with negative margins following complete resection
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Diagnosed with cervical esophageal carcinoma
* Diagnosed with Stage IV resectable disease
* Did not receive concurrent chemoradiotherapy prior to surgery
* Participants who have received a live/attenuated vaccine within 30 days of the first treatment

Other protocol defined Inclusion/exclusion criteria could apply

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s


The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Active, not recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
14/07/2016
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
11/10/2025
Actual
Sample size
Target
Accrual to date
Final
794
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,VIC,WA
Recruitment hospital [1] 0 0
Local Institution - 0200 - Blacktown
Recruitment hospital [2] 0 0
Local Institution - 0098 - Gosford
Recruitment hospital [3] 0 0
Local Institution - 0074 - St Leonards
Recruitment hospital [4] 0 0
Local Institution - 0075 - Tamworth
Recruitment hospital [5] 0 0
Local Institution - 0237 - Brisbane
Recruitment hospital [6] 0 0
Local Institution - 0123 - Adelaide
Recruitment hospital [7] 0 0
Local Institution - 0072 - Clayton
Recruitment hospital [8] 0 0
Local Institution - 0156 - Perth
Recruitment hospital [9] 0 0
Local Institution - 0099 - Hobart
Recruitment postcode(s) [1] 0 0
2148 - Blacktown
Recruitment postcode(s) [2] 0 0
2250 - Gosford
Recruitment postcode(s) [3] 0 0
2065 - St Leonards
Recruitment postcode(s) [4] 0 0
2340 - Tamworth
Recruitment postcode(s) [5] 0 0
4102 - Brisbane
Recruitment postcode(s) [6] 0 0
5000 - Adelaide
Recruitment postcode(s) [7] 0 0
3168 - Clayton
Recruitment postcode(s) [8] 0 0
6150 - Perth
Recruitment postcode(s) [9] 0 0
7000 - Hobart
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Arizona
Country [2] 0 0
United States of America
State/province [2] 0 0
California
Country [3] 0 0
United States of America
State/province [3] 0 0
Colorado
Country [4] 0 0
United States of America
State/province [4] 0 0
District of Columbia
Country [5] 0 0
United States of America
State/province [5] 0 0
Florida
Country [6] 0 0
United States of America
State/province [6] 0 0
Illinois
Country [7] 0 0
United States of America
State/province [7] 0 0
Maryland
Country [8] 0 0
United States of America
State/province [8] 0 0
Massachusetts
Country [9] 0 0
United States of America
State/province [9] 0 0
Missouri
Country [10] 0 0
United States of America
State/province [10] 0 0
New Jersey
Country [11] 0 0
United States of America
State/province [11] 0 0
New York
Country [12] 0 0
United States of America
State/province [12] 0 0
North Carolina
Country [13] 0 0
United States of America
State/province [13] 0 0
Ohio
Country [14] 0 0
United States of America
State/province [14] 0 0
Oregon
Country [15] 0 0
United States of America
State/province [15] 0 0
Pennsylvania
Country [16] 0 0
United States of America
State/province [16] 0 0
Tennessee
Country [17] 0 0
United States of America
State/province [17] 0 0
Texas
Country [18] 0 0
United States of America
State/province [18] 0 0
Washington
Country [19] 0 0
United States of America
State/province [19] 0 0
Wisconsin
Country [20] 0 0
Argentina
State/province [20] 0 0
Buenos Aires
Country [21] 0 0
Argentina
State/province [21] 0 0
Distrito Federal
Country [22] 0 0
Argentina
State/province [22] 0 0
RIO Negro
Country [23] 0 0
Argentina
State/province [23] 0 0
Santa FE
Country [24] 0 0
Argentina
State/province [24] 0 0
Tucuman
Country [25] 0 0
Argentina
State/province [25] 0 0
Caba
Country [26] 0 0
Argentina
State/province [26] 0 0
Cordoba
Country [27] 0 0
Belgium
State/province [27] 0 0
Bruxelles
Country [28] 0 0
Belgium
State/province [28] 0 0
Edegem
Country [29] 0 0
Belgium
State/province [29] 0 0
Gent
Country [30] 0 0
Belgium
State/province [30] 0 0
Leuven
Country [31] 0 0
Belgium
State/province [31] 0 0
Liege
Country [32] 0 0
Belgium
State/province [32] 0 0
Namur
Country [33] 0 0
Brazil
State/province [33] 0 0
Distrito Federal
Country [34] 0 0
Brazil
State/province [34] 0 0
Minas Gerais
Country [35] 0 0
Brazil
State/province [35] 0 0
Parana
Country [36] 0 0
Brazil
State/province [36] 0 0
RIO Grande DO SUL
Country [37] 0 0
Brazil
State/province [37] 0 0
Santa Catarina
Country [38] 0 0
Brazil
State/province [38] 0 0
Sao Paulo
Country [39] 0 0
Brazil
State/province [39] 0 0
Rio de Janeiro
Country [40] 0 0
Brazil
State/province [40] 0 0
Salvador
Country [41] 0 0
Canada
State/province [41] 0 0
Alberta
Country [42] 0 0
Canada
State/province [42] 0 0
British Columbia
Country [43] 0 0
Canada
State/province [43] 0 0
Nova Scotia
Country [44] 0 0
Canada
State/province [44] 0 0
Ontario
Country [45] 0 0
Canada
State/province [45] 0 0
Quebec
Country [46] 0 0
China
State/province [46] 0 0
Beijing
Country [47] 0 0
China
State/province [47] 0 0
Fujian
Country [48] 0 0
China
State/province [48] 0 0
Shanghai
Country [49] 0 0
China
State/province [49] 0 0
Zhejiang
Country [50] 0 0
China
State/province [50] 0 0
Tianjin
Country [51] 0 0
Czechia
State/province [51] 0 0
Brno
Country [52] 0 0
Czechia
State/province [52] 0 0
Hradec Kralove
Country [53] 0 0
Czechia
State/province [53] 0 0
Olomouc
Country [54] 0 0
Denmark
State/province [54] 0 0
Aarhus N
Country [55] 0 0
France
State/province [55] 0 0
Avignon Cedes 9
Country [56] 0 0
France
State/province [56] 0 0
Dijon Cedex
Country [57] 0 0
France
State/province [57] 0 0
Lille
Country [58] 0 0
France
State/province [58] 0 0
Paris
Country [59] 0 0
France
State/province [59] 0 0
Pessac
Country [60] 0 0
France
State/province [60] 0 0
Pierre Benite Cedex
Country [61] 0 0
France
State/province [61] 0 0
Rennes Cedex 9
Country [62] 0 0
France
State/province [62] 0 0
Rouen
Country [63] 0 0
France
State/province [63] 0 0
Toulouse
Country [64] 0 0
Germany
State/province [64] 0 0
Rheinland-Pfalz
Country [65] 0 0
Germany
State/province [65] 0 0
Berlin
Country [66] 0 0
Germany
State/province [66] 0 0
Essen
Country [67] 0 0
Germany
State/province [67] 0 0
Hamburg
Country [68] 0 0
Germany
State/province [68] 0 0
Koeln
Country [69] 0 0
Germany
State/province [69] 0 0
Marburg
Country [70] 0 0
Germany
State/province [70] 0 0
Munich
Country [71] 0 0
Germany
State/province [71] 0 0
Tuebingen
Country [72] 0 0
Hong Kong
State/province [72] 0 0
Hong Kong
Country [73] 0 0
Hungary
State/province [73] 0 0
Budapest
Country [74] 0 0
Hungary
State/province [74] 0 0
Debrecen
Country [75] 0 0
Hungary
State/province [75] 0 0
Kaposvar
Country [76] 0 0
Ireland
State/province [76] 0 0
Cork
Country [77] 0 0
Ireland
State/province [77] 0 0
Dublin
Country [78] 0 0
Ireland
State/province [78] 0 0
Galway
Country [79] 0 0
Israel
State/province [79] 0 0
Haifa
Country [80] 0 0
Israel
State/province [80] 0 0
Jerusalem
Country [81] 0 0
Israel
State/province [81] 0 0
Petach Tikva
Country [82] 0 0
Israel
State/province [82] 0 0
Ramat-gan
Country [83] 0 0
Israel
State/province [83] 0 0
Tel Aviv
Country [84] 0 0
Italy
State/province [84] 0 0
Bergamo
Country [85] 0 0
Italy
State/province [85] 0 0
Milano
Country [86] 0 0
Italy
State/province [86] 0 0
Reggio Emilia
Country [87] 0 0
Italy
State/province [87] 0 0
Roma
Country [88] 0 0
Japan
State/province [88] 0 0
Akita
Country [89] 0 0
Japan
State/province [89] 0 0
Chiba
Country [90] 0 0
Japan
State/province [90] 0 0
Fukuoka
Country [91] 0 0
Japan
State/province [91] 0 0
Gifu
Country [92] 0 0
Japan
State/province [92] 0 0
Hiroshima
Country [93] 0 0
Japan
State/province [93] 0 0
Hokkaido
Country [94] 0 0
Japan
State/province [94] 0 0
Kagoshima
Country [95] 0 0
Japan
State/province [95] 0 0
Kumamoto
Country [96] 0 0
Japan
State/province [96] 0 0
Miyagi
Country [97] 0 0
Japan
State/province [97] 0 0
Osaka
Country [98] 0 0
Japan
State/province [98] 0 0
Saitama
Country [99] 0 0
Japan
State/province [99] 0 0
Tokyo
Country [100] 0 0
Japan
State/province [100] 0 0
Kita-gun
Country [101] 0 0
Korea, Republic of
State/province [101] 0 0
Seoul
Country [102] 0 0
Mexico
State/province [102] 0 0
Chiapas
Country [103] 0 0
Mexico
State/province [103] 0 0
Distrito Federal C.p.
Country [104] 0 0
Mexico
State/province [104] 0 0
Guanajuato
Country [105] 0 0
Mexico
State/province [105] 0 0
Aguascalientes
Country [106] 0 0
Mexico
State/province [106] 0 0
Ciudad de Mexico
Country [107] 0 0
Mexico
State/province [107] 0 0
Distrito Federal
Country [108] 0 0
Netherlands
State/province [108] 0 0
Amsterdam
Country [109] 0 0
Netherlands
State/province [109] 0 0
Groningen
Country [110] 0 0
Netherlands
State/province [110] 0 0
Maastrict
Country [111] 0 0
Peru
State/province [111] 0 0
Callao
Country [112] 0 0
Peru
State/province [112] 0 0
Lima
Country [113] 0 0
Poland
State/province [113] 0 0
Wielkopolskie
Country [114] 0 0
Poland
State/province [114] 0 0
Gliwice
Country [115] 0 0
Poland
State/province [115] 0 0
Krakow
Country [116] 0 0
Poland
State/province [116] 0 0
Lublin
Country [117] 0 0
Poland
State/province [117] 0 0
Warszawa
Country [118] 0 0
Puerto Rico
State/province [118] 0 0
San Juan
Country [119] 0 0
Romania
State/province [119] 0 0
Baia Mare
Country [120] 0 0
Romania
State/province [120] 0 0
Bucharest
Country [121] 0 0
Romania
State/province [121] 0 0
Bucuresti
Country [122] 0 0
Romania
State/province [122] 0 0
Cluj-napoca
Country [123] 0 0
Romania
State/province [123] 0 0
Craiova
Country [124] 0 0
Romania
State/province [124] 0 0
Floresti
Country [125] 0 0
Russian Federation
State/province [125] 0 0
Cheboksary
Country [126] 0 0
Russian Federation
State/province [126] 0 0
Moscow
Country [127] 0 0
Russian Federation
State/province [127] 0 0
Saint-Petersburg
Country [128] 0 0
Russian Federation
State/province [128] 0 0
St. Petersburg
Country [129] 0 0
Singapore
State/province [129] 0 0
Singapore
Country [130] 0 0
Spain
State/province [130] 0 0
Barcelona
Country [131] 0 0
Spain
State/province [131] 0 0
Cordoba
Country [132] 0 0
Spain
State/province [132] 0 0
Madrid
Country [133] 0 0
Switzerland
State/province [133] 0 0
Basel
Country [134] 0 0
Switzerland
State/province [134] 0 0
St Gallen
Country [135] 0 0
Taiwan
State/province [135] 0 0
Taichung
Country [136] 0 0
Taiwan
State/province [136] 0 0
Tainan
Country [137] 0 0
Taiwan
State/province [137] 0 0
Taipei
Country [138] 0 0
Turkey
State/province [138] 0 0
Adana
Country [139] 0 0
Turkey
State/province [139] 0 0
Erzurum
Country [140] 0 0
Turkey
State/province [140] 0 0
Istanbul
Country [141] 0 0
United Kingdom
State/province [141] 0 0
Greater London
Country [142] 0 0
United Kingdom
State/province [142] 0 0
Hampshire
Country [143] 0 0
United Kingdom
State/province [143] 0 0
Manchester
Country [144] 0 0
United Kingdom
State/province [144] 0 0
Surrey
Country [145] 0 0
United Kingdom
State/province [145] 0 0
Cardiff
Country [146] 0 0
United Kingdom
State/province [146] 0 0
London

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Bristol-Myers Squibb
Address
Country
Other collaborator category [1] 0 0
Commercial sector/industry
Name [1] 0 0
Ono Pharmaceutical Co. Ltd
Address [1] 0 0
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
The primary purpose of this study is to determine whether Nivolumab will improve disease-free survival compared with placebo.
Trial website
https://clinicaltrials.gov/study/NCT02743494
Trial related presentations / publications
Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, Mendez G, Feliciano J, Motoyama S, Lievre A, Uronis H, Elimova E, Grootscholten C, Geboes K, Zafar S, Snow S, Ko AH, Feeney K, Schenker M, Kocon P, Zhang J, Zhu L, Lei M, Singh P, Kondo K, Cleary JM, Moehler M; CheckMate 577 Investigators. Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer. N Engl J Med. 2021 Apr 1;384(13):1191-1203. doi: 10.1056/NEJMoa2032125. Erratum In: N Engl J Med. 2023 Feb 16;388(7):672. doi: 10.1056/NEJMx220014.
Public notes

Contacts
Principal investigator
Name 0 0
Bristol-Myers Squibb
Address 0 0
Bristol-Myers Squibb
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/study/NCT02743494